Safety, Marketing and Regulations

Safety, Marketing and Regulations

safety and marketing of pharmaceuticals


Many states are looking to reduce prescription drug abuse, overdose and misuse, and have enacted different types of legislation to address this increasingly important public health issue. The tables below includes information and links about examples of state laws, recent state legislation, and 2009-2012 enacted legislation that aims to prevent deaths and injuries from prescription drug abuse, overdose and misuse.





Compounding pharmacies are a long-standing yet less frequently discussed element in the complex matrix of prescription drug manufacturing, distribution and patient use. The term refers to any physical pharmacy that is licensed to mix or "compound" chemical ingredients into a finished medication ready to use by an individual patient, based on a prescription ordered by a physician or other legally authorized prescriber.





An alarming number of patients fail to take their medicine as prescribed, also known as “non-adherence” or “non-compliance,” which can lead to worsening of disease and even sudden death. This practice also results in between 33 percent and 39 percent of all medication-related hospital admissions in the U.S., costing roughly $100 billion annually.   [MORE GO 20287]

States also grapple with increasing misuse and illegal abuse of prescription drugs, by enacting drug monitoring programs, as well as prevention and education strategies.

Several states have attempted to legislate different aspects of Direct-to-Consumer Advertising (DTCA) of pharmaceuticals, including marketing and promoting drugs to doctors. Some argue the high cost of drugs, in part, is due to the amount of advertising done by drug companies. [MORE – GO 14461]



Share this: 


New Members Welcome


  • PHARMACEUTICALS: Facts, Policies and NCSL Resources

    This compendium describes a range of facts and policy resources about states and pharmaceuticals. 2014 reports reveal 86% of filled prescriptions are generic products, while specialty drugs prices increased 14-15% in one year.

  • Drug Shortages: Preserving the Drug Supply

    The FDA has released their strategic plan to face the challenges of the drug shortages in the U.S., followed by a release of proposed rules requiring manufacturer reporting.

We are the nation's most respected bipartisan organization providing states support, ideas, connections and a strong voice on Capitol Hill.

NCSL Member Toolbox


7700 East First Place
Denver, CO 80230
Tel: 303-364-7700 | Fax: 303-364-7800


444 North Capitol Street, N.W., Suite 515
Washington, D.C. 20001
Tel: 202-624-5400 | Fax: 202-737-1069

Copyright 2014 by National Conference of State Legislatures